• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

International Isotopes adjusts financial outlook

Article

Radioisotope manufacturer International Isotopes of Denton, TX, last month announced that it expects slower 1999 revenue growth than initially anticipated. The company attributed its adjusted financial outlook to modified product specifications and an

Radioisotope manufacturer International Isotopes of Denton, TX, last month announced that it expects slower 1999 revenue growth than initially anticipated. The company attributed its adjusted financial outlook to modified product specifications and an underestimation of the time, cost, and complexity of obtaining state and federal regulatory approval for its manufacturing facilities. International Isotopes expects its revenues to increase, but will report operating losses this fiscal year.

In its effort to meet its revised timetable for product shipments, the company has created a six-point plan that focuses on products closest to clearance. International Isotopes is seeking a permanent COO to help guide the company through the plan, as well as a professional to supervise the regulatory process. President Carl Seidel will focus on brachytherapy device production, while others on the company’s management team will concentrate on radioisotope and radiopharmaceutical manufacture. The company also plans to tighten its belt by eliminating unnecessary production costs. Finally, International Isotopes will explore creative financing options, including joint ventures, to support its operations and new product development.

In other International Isotopes news, the firm on July 19 gained rights to an exclusive worldwide license to manufacture palladium-103 brachytherapy seeds for the treatment of prostate cancer when it signed an agreement with Endotech for access to Endotech’s patents.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.